Midi Health Review

Midi Health is a menopause clinic that happens to prescribe GLP-1s — not a weight-loss shop

The single most important thing to understand about Midi Health is what it is not. This is not a fast-lane, fill-out-a-form-and-get-a-shot GLP-1 service. Midi is a nationwide menopause and perimenopause telehealth platform, and semaglutide shows up here as one tool inside a broader midlife-women's-health plan — usually alongside hormone therapy and other metabolic support. If you're a woman in your 40s or 50s whose weight gain, sleep, mood, and hot flashes all arrived together, that framing is a feature, not a bug. If your only goal is to lose weight as quickly and cheaply as possible, Midi is probably the wrong door to knock on.

How the pricing actually works (and why you won't see a medication price)

Most GLP-1 telehealth brands quote you a single all-in monthly number that bundles the drug and the visit. Midi does not work that way, and that catches people off guard. Midi publishes visit fees only — never a medication price. On the self-pay path you pay one fee for the initial visit and a lower fee for each continued-care visit, and the GLP-1 medication is billed separately on top of that. There is no published per-dose price and no compounded-medication rate anywhere on the current site, so you genuinely cannot know your total monthly cost until you've had the consult and seen what your pharmacy and insurance do.

For context, the typical all-in GLP-1 telehealth plan in our database runs around $170 a month. Midi's structure makes a direct apples-to-apples comparison impossible — your final number depends on whether you go through insurance or self-pay, and on the medication your clinician chooses. Go in expecting a visit fee plus a separate medication bill, not one tidy subscription price.

The insurance angle is Midi's real edge

Here's where Midi genuinely separates itself from the cash-pay-only crowd: it accepts commercial insurance. If your plan covers the visit, you pay only your standard copay and deductible for both the initial and follow-up appointments instead of the self-pay fees. For a lot of women that turns an expensive-looking service into a low-copay one, and it's a meaningful differentiator in a market where most GLP-1 startups won't touch insurance at all.

But read the fine print, because Midi is blunt about it: it does not work with Medicare, Medicaid, or Medi-Cal. The site says plainly that it cannot treat Medicaid or Medi-Cal patients at this time, even as self-pay patients, and that it is not covered by Medicare or any Medicare-related plan. If you're on any of those programs, Midi simply isn't an option — not a discount-it-down situation, a hard no.

What's actually prescribed, and how

• Compounded [semaglutide](/drugs/semaglutide) is the GLP-1 on offer, described on Midi's weight page as personalized GLP-1 injectables within a customized treatment plan.
• No brand-name pricing is published — don't expect a guaranteed route to brand Wegovy or Ozempic here.
• The medication is dispensed separately from your visit, billed through your insurance or paid out of pocket, not bundled into the consult fee.
• Prescribing is clinician-discretionary. A GLP-1 is offered when the clinician judges it appropriate inside your menopause and metabolic plan — it is not promised at intake.

That last point matters and deserves to be said honestly: you are not guaranteed a prescription when you sign up. Midi's clinicians decide whether a GLP-1 fits your overall midlife-health picture. That's clinically responsible, but if you arrive expecting an automatic yes, you may be disappointed.

Who should choose Midi — and who should walk

Midi is a strong fit for women navigating perimenopause or menopause who want one team handling hormones and metabolic health together — the stage of life where GLP-1 efficacy and stubborn midlife weight regulation overlap most. The all-50-states coverage means it works regardless of where you live, and the insurance acceptance can make it surprisingly affordable if your plan plays along.

Skip it if you're a man, a younger woman whose sole focus is weight loss, or anyone on Medicare or Medicaid. Skip it too if price transparency is your top priority — the visit-fee-plus-separate-medication model leaves real uncertainty about your monthly total until you're already a patient. People who want a single, locked-in, all-in monthly price will find that frustrating here.

Trust, oversight, and how confident we are

On the safety side, Midi reads well. There are no FDA warning letters on file for this provider, and the menopause-specialty framing means GLP-1s are layered into a supervised, whole-person care plan rather than handed out in isolation. The trade-off for that confidence is that Midi is less transparent than we'd like on the money side — no published medication price and no listed compounding-pharmacy partner means a few details we normally verify aren't disclosed publicly. We rate our verification confidence here as moderate: the care model and state coverage are well-documented, but the medication economics are not. You can see how we weigh these factors in our scoring methodology.

Bottom line

Midi Health is the right call for midlife women who want menopause care and metabolic support — including a possible GLP-1 — from one insurance-friendly, nationwide clinic, and who don't mind that the medication isn't guaranteed or priced up front. It's the wrong call for pure weight-loss shoppers, anyone on government insurance, and anyone who needs to know their exact monthly cost before they commit. Judge Midi as a menopause specialist that prescribes GLP-1s when warranted, not as a budget weight-loss service, and it's a solid, legitimately credentialed choice.

If you're weighing alternatives, Telos Rx ($49/month) and bmiMD ($99/month) are among the closest options we track to Midi Health.